North America Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy, and Research), and End-User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)
The North America circulating tumor cell (CTC) diagnostics market is expected to reach US$ 1,664.0 million by 2028 from US$ 861.6 million in 2021. The market is estimated to grow at a CAGR of 9.9% from 2021 to 2028.
Health systems in this region are witnessing a substantial increase in the prevalence of cancer. According to the International Agency for Research on Cancer (IARC), cancer burden in North America has increased to 19.3 million cases and 9.96 million cancer deaths as of 2020. A study published by the National Cancer Institute estimated the cancer incidence in the US at 1.9 million in 2021. ~0.6 million people were anticipated to die in 2021 in the US due to cancer. Thus, the increased prevalence of cancer across North America is propelling the demand for circulating tumor cell (CTC) diagnostics. The analysis and detection of circulating tumor cells assist in early patient diagnosis, and prognosis helps determine accurate treatment for the patient. The CTC diagnostics can be used to detect various types of cancers, including prostate cancer, breast cancer, colorectal cancer, kidney cancer, lymphomas, lung cancer, and melanoma. There has been a high demand for CTC diagnostics in recent years due to its reliability and accuracy in identifying the risk of the disease and monitoring its treatments.
The impact of the COVID-19 pandemic on cancer patients, cancer surveillance capacities, and the whole American health system has been notable. Reduced resources and limited healthcare capacity made cancer detection and treatment more difficult, resulting in lower incidence, higher mortality, and lower survival in the future. Because of a compromised immune system caused by cancer and/or its treatment (e.g., surgery and chemotherapy), people with active cancer are more susceptible to infectious pathogens. Thus, the risk of COVID-19 severity and mortality may be more common in cancer patients. Males; people of age 60 and above; people with a history of smoking; populations suffering from obesity, hypertension, cardiovascular disease, and diabetes have all been consistently related to an elevated risk of severe disease and/or death. Findings relating to prognosis for cancer-associated variables have proven conflicting.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the circulating tumor cell (CTC) diagnostics market in North America at a good CAGR during the forecast period.
North America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report :
North America Circulating Tumor Cell (CTC) Diagnostics Market Segmentation
By Technology
- CTC detection and Enrichment Method
- CTC Direct Detection Methods
- CTC Analysis
By Application
- Clinical/Liquid Biopsy
- Risk Assessment
- Screening and Monitoring
- Research
- Cancer Stem Cell and Tumorigenesis Research
- Drug/Therapy Development
By End-User
- Hospitals and Clinics
- Research and Academic Institutes
- Diagnostic Centers
By Country
- US
- Canada
- Mexico
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Stemcell Technologies Inc.
- Qiagen
- Precision Medicine Group, Llc
- Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
- Epic Lifesciences
- Screencell
- Ikonisys, Inc
- IVdiagnostics
- Fluxion Bioscience
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Circulating Tumor Cell (CTC) Diagnostics Market – By Technology
1.3.2 North America Circulating Tumor Cell (CTC) Diagnostics Market – By Application
1.3.3 North America Circulating Tumor Cell (CTC) Diagnostics Market – By End-User
1.3.4 North America Circulating Tumor Cell (CTC) Diagnostics Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Circulating Tumor Cell (CTC) Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. Circulating Tumor Cell (CTC) Diagnostics Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cancer
5.1.2 Rising Demand for Minimally Invasive Diagnostic Procedures
5.2 Market Restraints
5.2.1 Dearth of Skilled Professionals Performing Diagnostic Procedures
5.3 Market Opportunities
5.3.1 Untapped Potential of Emerging Economies
5.4 Future Trends
5.4.1 Technological Advancements in Isolation of Circulating Tumor Cell
5.5 Impact Analysis
6. Circulating Tumor Cell (CTC) Diagnostics Market– North America Analysis
6.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis
6.2 Market Positioning of Key Players
7. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Technology
7.1 Overview
7.2 North America Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2020 & 2028 (%)
7.3 CTC detection and Enrichment Method
7.3.1 Overview
7.3.2 CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
7.4 CTC Direct Detection Method
7.4.1 Overview
7.4.2 CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
7.5 CTC Analysis
7.5.1 Overview
7.5.2 CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Application
8.1 Overview
8.2 North America Circulating Tumor Cell (CTC) Diagnostics Market Share, By Application - 2020 & 2028 (%)
8.3 Clinical/Liquid Biopsy
8.3.1 Overview
8.3.2 Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.3 Risk Assessment
8.3.3.1 Overview
8.3.3.2 Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.4 Screening and Monitoring
8.3.4.1 Overview
8.3.4.2 Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Research
8.4.1 Overview
8.4.2 Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4.2.1 Cancer Stem Cell & Tumorigenesis Research
8.4.2.1.1 Overview
8.4.2.1.2 Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4.2.2 Drug/Therapy Development
8.4.2.2.1 Overview
8.4.2.2.2 Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – End user
9.1 Overview
9.2 North America Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Research and Academic Institutes
9.4.1 Overview
9.4.2 Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Diagnostic Centers
9.5.1 Overview
9.5.2 Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. North America Circulating Tumor Cell (CTC) Diagnostics Market – Geographic Analysis
10.1 North America: Circulating Tumor Cell (CTC) Diagnostics Market
10.1.1 Overview
10.1.2 North America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)
10.1.4 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)
10.1.4.1 North America Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.1.4.2 North America Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.1.5 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)
10.1.6 North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)
10.1.6.1.4 US: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)
10.1.6.1.4.1 US Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.1.6.1.4.2 US Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.1.6.1.5 US: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)
10.1.7 Canada: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.7.1.1 Overview
10.1.7.1.2 Canada: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.7.1.3 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)
10.1.7.1.4 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)
10.1.7.1.4.1 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.1.7.1.4.2 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.1.7.1.5 Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)
10.1.7.2 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.7.2.1 Overview
10.1.7.2.2 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.7.2.3 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2019–2028 (US$ Million)
10.1.7.2.4 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Application, 2019–2028 (US$ Million)
10.1.7.2.4.1 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)
10.1.7.2.4.2 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)
10.1.7.2.5 Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by End User, 2019–2028 (US$ Million)
11. Impact of COVID-19 Pandemic on North America Circulating Tumor Cell (CTC) Diagnostics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 STEMCELL Technologies Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Precision Medicine Group, LLC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 EPIC SCIENCES, INC.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 SCREENCELL
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 IKONISYS, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 IVDiagnostics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 FLUXION BIOSCIENCES
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)
Table 5. North America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)
Table 6. US Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Circulating Tumor Cell (CTC) Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)
Table 10. US Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)
Table 11. Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)
Table 15. Canada Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)
Table 16. Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)
Table 20. Mexico Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)
Table 21. Organic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market
Table 22. Inorganic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market
Table 23. Glossary of Terms, Circulating Tumor Cell (CTC) Diagnostics Market
LIST OF FIGURES
Figure 1. Circulating Tumor Cell (CTC) Diagnostics Market Segmentation
Figure 2. North America Circulating Tumor Cell (CTC) Diagnostics Market Overview
Figure 3. CTC detection and Enrichment Method Held Largest Share of Technology Segment in Circulating Tumor Cell (CTC) Diagnostics Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Circulating Tumor Cell (CTC) Diagnostics Market, Industry Landscape
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Circulating Tumor Cell (CTC) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 9. Market Positioning of Key Players in North America Circulating Tumor Cell (CTC) Diagnostics Market
Figure 10. North America Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2020 & 2028 (%)
Figure 11. CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Circulating Tumor Cell (CTC) Diagnostics Market Share, by Application - 2020 & 2028 (%)
Figure 15. Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)
Figure 22. Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 26. North America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 28. US: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Canada: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Mexico: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Impact of COVID-19 Pandemic in North American Country Markets
Figure 32. Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)
- THERMO FISHER SCIENTIFIC INC.
- STEMCELL Technologies Inc.
- QIAGEN
- Precision Medicine Group, LLC
- ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)
- EPIC LIFESCIENCES
- SCREENCELL
- IKONISYS, INC
- IVDiagnostics
- FLUXION BIOSCIENCES
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America circulating tumor cell (CTC) diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America circulating tumor cell (CTC) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.